Achieve Life Sciences Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Achieve Life Sciences stock.
View analyst ratings for Achieve Life Sciences or view top-rated stocks.

Wall Street analysts have given Achieve Life Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Achieve Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Achieve Life Sciences is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Achieve Life Sciences.

Achieve Life Sciences, Inc. (NASDAQ:ACHV) posted its quarterly earnings data on Thursday, March, 11th. The biopharmaceutical company reported ($1.11) earnings per share for the quarter, beating the Zacks' consensus estimate of ($1.27) by $0.16.
View Achieve Life Sciences' earnings history.

Achieve Life Sciences' stock was trading at $8.3240 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACHV stock has increased by 19.3% and is now trading at $9.93.
View which stocks have been most impacted by COVID-19.

Achieve Life Sciences's stock reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of Achieve Life Sciences stock prior to the reverse split would have 5 shares after the split.

4 equities research analysts have issued 1-year target prices for Achieve Life Sciences' stock. Their forecasts range from $21.00 to $100.00. On average, they anticipate Achieve Life Sciences' share price to reach $50.33 in the next twelve months. This suggests a possible upside of 406.9% from the stock's current price.
View analysts' price targets for Achieve Life Sciences or view top-rated stocks among Wall Street analysts.

Some companies that are related to Achieve Life Sciences include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), United Therapeutics (UTHR) and Neurocrine Biosciences (NBIX).
View all of ACHV's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), Cannabics Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV."

Shares of ACHV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACHV stock can currently be purchased for approximately $9.93.

Achieve Life Sciences has a market capitalization of $61.07 million. The biopharmaceutical company earns $-16,400,000.00 in net income (profit) each year or ($39.80) on an earnings per share basis.

Achieve Life Sciences employs 13 workers across the globe.

The official website for Achieve Life Sciences is achievelifesciences.com.

Achieve Life Sciences is headquartered at 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1.

Achieve Life Sciences' mailing address is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. The biopharmaceutical company can be reached via phone at 604-210-2217 or via email at [email protected]